- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. However the net income and revenue declined. Shares are down 2.13%.
Vertex Pharmaceuticals Incorporated Earnings Cheat Sheet
Results: Net income decreased -94.33% to $9 million (4 cents per diluted share) in the quarter versus a net gain of $158.63 million in the year-earlier quarter.
Revenue: Decreased 40.71% to $334 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Vertex Pharmaceuticals Incorporated reported adjusted net income of 4 cents per share. It beat the average revenue estimate of $318.5 million.
Quoting Management: “Entering 2013, we are committed to advancing key development programs and to maintaining financial strength to position the company for sustainable long-term growth,” said Jeffrey Leiden, M.D., Ph.D., Chair, President and CEO of Vertex…
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.